Zacks analysts highlight IBM, Micron, and Abbott for their innovation-driven growth, solid fundamentals, and evolving market ...
IBM posts strong Q3 results as Watsonx and quantum bets boost growth, while Micron rides AI-driven memory demand and Abbott expands on device strength.
Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott FreeStyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback